Literature DB >> 23353160

[Preoperative platelet-lymphocyte ratio is an independent prognostic factor for resectable colorectal cancer].

Hailiang Liu1, Xiaohui DU, Peiming Sun, Chunhong Xiao, Yingxin Xu, Rong Li.   

Abstract

OBJECTIVE: To evaluate the impact of preoperative platelet-lymphocyte ratio (PLR) on the prognosis in patients with operable colorectal cancer.
METHODS: The clinical data of 140 patients with operable colorectal cancer were analyzed retrospectively. According to preoperative PLR, the patients were divided into low PLR group (PLR<250) and high PLR group (PLR≥250). The overall 5-year survival rates and the clinicopathological factors in the two groups were analyzed using univariate analysis and COX regression model.
RESULTS: The patients with a high PLR had a significantly lower overall 5-year survival rate than those with a low PLR (71.4% vs 51.5%, P=0.045). Univariate analyses identified tumor location, the depth of tumor invasion, lymph nodes metastasis, TMN stage, and PLR as significant risk factors for reduced overall 5-year survival. In COX regression model, a high PLR was identified as an independent risk factor for poorer prognosis in patients with resectable colorectal cancer (RR: 2.213; 95%CI: 1.007-4.863, P=0.0048).
CONCLUSION: Preoperative PLR can be a clinically significant factor for assessment of prognosis of resectable colorectal cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23353160

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  11 in total

1.  Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer.

Authors:  Qing Wang; Yang Yang; Ya-Ping Zhang; Zhengyun Zou; Xiaoping Qian; Baorui Liu; Jia Wei
Journal:  Med Oncol       Date:  2014-10-26       Impact factor: 3.064

2.  Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.

Authors:  Kyriakos Neofytou; Elizabeth C Smyth; Alexandros Giakoustidis; Aamir Z Khan; David Cunningham; Satvinder Mudan
Journal:  Med Oncol       Date:  2014-09-14       Impact factor: 3.064

3.  Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer.

Authors:  Zhen-Yu Zou; Hai-Liang Liu; Ning Ning; Song-Yan Li; Xiao-Hui DU; Rong Li
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

4.  Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer.

Authors:  Jing Jia; Xiongwei Zheng; Ying Chen; Lin Wang; Lu Lin; Xingming Ye; Yan Chen; Dedong Chen; Markus Dettke
Journal:  Tumour Biol       Date:  2015-06-25

5.  The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.

Authors:  Hou-Qun Ying; Qi-Wen Deng; Bang-Shun He; Yu-Qin Pan; Feng Wang; Hui-Ling Sun; Jie Chen; Xian Liu; Shu-Kui Wang
Journal:  Med Oncol       Date:  2014-10-30       Impact factor: 3.064

6.  The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.

Authors:  S Krenn-Pilko; U Langsenlehner; E-M Thurner; T Stojakovic; M Pichler; A Gerger; K S Kapp; T Langsenlehner
Journal:  Br J Cancer       Date:  2014-03-27       Impact factor: 7.640

7.  Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection.

Authors:  Özgür Akgül; Erdinç Çetinkaya; Metin Yalaza; Sabri Özden; Mesut Tez
Journal:  World J Gastrointest Oncol       Date:  2017-07-15

8.  The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.

Authors:  Ya-Huan Guo; Hai-Feng Sun; Yan-Bing Zhang; Zi-Jun Liao; Lei Zhao; Jie Cui; Tao Wu; Jian-Rong Lu; Ke-Jun Nan; Shu-Hong Wang
Journal:  Oncotarget       Date:  2017-03-21

Review 9.  Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.

Authors:  Dewen Tan; Yan Fu; Qi Su; Heling Wang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Abilities of Pre-Treatment Inflammation Ratios as Classification or Prediction Models for Patients with Colorectal Cancer.

Authors:  Andra Ciocan; Răzvan A Ciocan; Nadim Al Hajjar; Claudia D Gherman; Sorana D Bolboacă
Journal:  Diagnostics (Basel)       Date:  2021-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.